- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02367677
Digital Photographs to Evaluate Blepharoptosis
February 1, 2017 updated by: CHU de Quebec-Universite Laval
Comparison Between Clinical Measurements and Computer-based Measurements on Digital Photographs to Evaluate Blepharoptosis
To compare measurements made by a computer software (ImageJ) made on photographs to the traditional clinical measures with a ruler in the evaluation of blepharoptosis
Study Overview
Study Type
Observational
Enrollment (Actual)
36
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1S 4L8
- Centre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with ptosis of all causes
Description
Inclusion Criteria:
- Patients 18 years old or older
- Patients presenting for evaluation of blepharoptosis of any kind except the one mentioned in the exclusion criteria
Exclusion Criteria:
- Myasthenia gravis
- Thyroid eye disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Clinical measurements
Measurements are made with a paper ruler
|
|
Smartphone
Measurements are made with ImageJ from pictures taken with an iPhone 6
|
|
Digital camera
Measurements are made with ImageJ from pictures taken with a Nikon D700
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reliability of measurements made on photographs to evaluate blepharoptosis
Time Frame: Same day
|
Comparison between measurements made on digital photographs with measurements made with a ruler in clinic
|
Same day
|
Reliability of measurements made on photographs taken by smartphone to evaluate blepharoptosis
Time Frame: Same day
|
Comparison between measurements made on digital photographs taken by smartphone with measurements made on digital photographs taken with a digital camera
|
Same day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yvonne Molgat, MDCM, FRCSC, Centre de recherche du CHU de Québec : Université Laval
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
November 30, 2016
Study Completion (Actual)
November 30, 2016
Study Registration Dates
First Submitted
February 3, 2015
First Submitted That Met QC Criteria
February 13, 2015
First Posted (Estimate)
February 20, 2015
Study Record Updates
Last Update Posted (Estimate)
February 2, 2017
Last Update Submitted That Met QC Criteria
February 1, 2017
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-1905, C14-06-1905
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blepharoptosis
-
RVL Pharmaceuticals, Inc.CompletedAcquired BlepharoptosisUnited States
-
Levation Pharma, Ltd.Completed
-
Skelmet IncMassachusetts Eye and Ear InfirmaryCompleted
-
RVL Pharmaceuticals, Inc.CompletedBlepharoptosisUnited States
-
Cairo UniversityCompleted
-
University of MiamiCompleted
-
RVL Pharmaceuticals, Inc.Completed
-
Rabin Medical CenterUnknown
Clinical Trials on Method comparison
-
Meridian Bioscience, Inc.CompletedClostridium Difficile InfectionUnited States, Canada
-
Meridian Bioscience, Inc.CompletedPharyngitis, InfectiveUnited States, Canada
-
Meridian Bioscience, Inc.CompletedStreptococcus Agalactiae InfectionCanada, United States
-
Radiometer Medical ApSRecruiting
-
Hvidovre University HospitalOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsCompletedSARS-CoV2 Infection | COVID-19 TestingDenmark
-
Centre Hospitalier Universitaire de Saint EtienneCompletedAutoimmune DiseasesFrance
-
Gloucestershire Hospitals NHS Foundation TrustUnknownEsophageal Cancer | Precancerous ConditionUnited Kingdom
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Lung CancerUnited States
-
Federal University of São PauloCompletedStroke | Subarachnoid Hemorrhage | Intracranial Hypertension | Stroke, Ischemic | Stroke HemorrhagicBrazil
-
Brendon Gurd, PhDQueen's UniversityUnknown